The microbiome and its pharmacological targets: Therapeutic avenues in cardiometabolic diseases

Current Opinion in Pharmacology

Volumn 25, Issue , 2015, Pages 36-44

  Neves, Ana Luisa ^a   Chilloux, Julien ^a   Sarafian, Magali H ^a   Rahim, Mohd Badrin Abdul ^a   Boulangé, Claire L ^a,b   Dumas, Marc Emmanuel ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Metabometrix Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AROMATIC HYDROCARBON RECEPTOR; BILE ACID; BUTYRIC ACID; CHOLINE; FARNESOID X RECEPTOR; FFAR2 PROTEIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; HCAR2 PROTEIN; INDOLE; METHYLAMINE; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; TRIMETHYLAMINE OXIDE; TRYPTOPHAN; UNCLASSIFIED DRUG; INDOLE DERIVATIVE; PREBIOTIC AGENT; VOLATILE FATTY ACID;

AKKERMANSIA MUCINIPHILA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIOPHAGE; BIFIDOBACTERIUM ANIMALIS; CARDIOMETABOLIC DISEASE; CUTC GENE; CUTD GENE; DIET SUPPLEMENTATION; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FERMENTATION; GLUCOSE HOMEOSTASIS; HEART DISEASE; IMMUNOREGULATION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LIPID STORAGE; METABOLIC DISORDER; METABOLIC REGULATION; MICROBIOME; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; DIET THERAPY; DRUG EFFECTS; HUMAN; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; FATTY ACIDS, VOLATILE; GASTROINTESTINAL MICROBIOME; HUMANS; INDOLES; METABOLIC SYNDROME X; METHYLAMINES; MODELS, BIOLOGICAL; PREBIOTICS; PROBIOTICS; SIGNAL TRANSDUCTION;

EID: 84945276324     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.09.013     Document Type: Review

References (65)

1. R. Kahn, J. Buse, E. Ferrannini, and M. Stern The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 48 2005 1684 1699
2. P.D. Cani, and N.M. Delzenne The gut microbiome as therapeutic target Pharmacol Ther 130 2011 202 212
3. S. Shoaie, P. Ghaffari, P. Kovatcheva-Datchary, A. Mardinoglu, P. Sen, E. Pujos-Guillot, T. de Wouters, C. Juste, S. Rizkalla, J. Chilloux, and et al. Quantifying diet-induced metabolic changes of the human gut microbiome Cell Metab 22 2015 320 331
4. E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. Arumugam, J.-M. Batto, S. Kennedy, and et al. Richness of human gut microbiome correlates with metabolic markers Nature 500 2013 541 546
5. A. Cotillard, S.P. Kennedy, L.C. Kong, E. Prifti, N. Pons, E. Le Chatelier, M. Almeida, B. Quinquis, F. Levenez, N. Galleron, and et al. Dietary intervention impact on gut microbial gene richness Nature 500 2013 585 588
6. F.H. Karlsson, V. Tremaroli, I. Nookaew, G. Bergstrom, C.J. Behre, B. Fagerberg, J. Nielsen, and F. Backhed Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103
7. M.-E. Dumas The microbial-mammalian metabolic axis: beyond simple metabolism Cell Metab 13 2011 489 490
8. G. den Besten, K. van Eunen, A.K. Groen, K. Venema, D.-J. Reijngoud, and B.M. Bakker The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism J Lipid Res 54 2013 2325 2340
9. W.E. Roediger Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man Gut 21 1980 793 798
10. D.R. Donohoe, N. Garge, X.X. Zhang, W. Sun, T.M. O'Connell, M.K. Bunger, and S.J. Bultman The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon Cell Metab 13 2011 517 526
11. J.H. Cummings Short chain fatty acids in the human colon Gut 22 1981 763 779
12. G. Frost, M.L. Sleeth, M. Sahuri-Arisoylu, B. Lizarbe, S. Cerdan, L. Brody, J. Anastasovska, S. Ghourab, M. Hankir, S. Zhang, and et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism Nat Commun 5 2014 3611
13. H. Yadav, J.-H. Lee, J. Lloyd, P. Walter, and S.G. Rane Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion J Biol Chem 288 2013 25088 25097
14. G. Tolhurst, H. Heffron, Y.S. Lam, H.E. Parker, A.M. Habib, E. Diakogiannaki, J. Cameron, J. Grosse, F. Reimann, and F.M. Gribble Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 Diabetes 61 2012 364 371
15. A. Psichas, M.L. Sleeth, K.G. Murphy, L. Brooks, G.A. Bewick, A.C. Hanyaloglu, M.A. Ghatei, S.R. Bloom, and G. Frost The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents Int J Obes 39 2015 424 429
16. L.B. Bindels, E.M. Dewulf, and N.M. Delzenne GPR43/FFA2: physiopathological relevance and therapeutic prospects Trends Pharmacol Sci 34 2013 226 232
17. I. Kimura, K. Ozawa, D. Inoue, T. Imamura, K. Kimura, T. Maeda, K. Terasawa, D. Kashihara, K. Hirano, T. Tani, and et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 Nat Commun 4 2013 1829
18. W.R. Russell, L. Hoyles, H.J. Flint, and M.E. Dumas Colonic bacterial metabolites and human health Curr Opin Microbiol 16 2013 246 254
19. Y. Xiong, N. Miyamoto, K. Shibata, M.A. Valasek, T. Motoike, R.M. Kedzierski, and M. Yanagisawa Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41 Proc Natl Acad Sci U S A 101 2004 1045 1050
20. F. De Vadder, P. Kovatcheva-Datchary, D. Goncalves, J. Vinera, C. Zitoun, A. Duchampt, F. Backhed, and G. Mithieux Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits Cell 156 2014 84 96
21. J.E. Digby, F. Martinez, A. Jefferson, N. Ruparelia, J. Chai, M. Wamil, D.R. Greaves, and R.P. Choudhury Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms Arterioscler Thromb Vasc Biol 32 2012 669 676
22. M. Thangaraju, G.A. Cresci, K. Liu, S. Ananth, J.P. Gnanaprakasam, D.D. Browning, J.D. Mellinger, S.B. Smith, G.J. Digby, N.A. Lambert, and et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon Cancer Res 69 2009 2826 2832
23. S. Craciun, J.A. Marks, and E.P. Balskus Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes ACS Chem Biol 9 2014 1408 1413
24. K.A. Romano, E.I. Vivas, D. Amador-Noguez, and F.E. Rey Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide MBio 6 2015 e02481
25. M.-E. Dumas, R.H. Barton, A. Toye, O. Cloarec, C. Blancher, A. Rothwell, J. Fearnside, R. Tatoud, V. Blanc, J.C. Lindon, and et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc Natl Acad Sci U S A 103 2006 12511 12516
26. R.A. Koeth, Z. Wang, B.S. Levison, J.A. Buffa, E. Org, B.T. Sheehy, E.B. Britt, X. Fu, Y. Wu, L. Li, and et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis Nat Med 19 2013 576 585
27. M. Troseid, T. Ueland, J.R. Hov, A. Svardal, I. Gregersen, C.P. Dahl, S. Aakhus, E. Gude, B. Bjorndal, B. Halvorsen, and et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure J Intern Med 277 2015 717 726
28. D.M. Shih, Z. Wang, R. Lee, Y. Meng, N. Che, S. Charugundla, H. Qi, J. Wu, C. Pan, J.M. Brown, and et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis J Lipid Res 56 2015 22 37
29. J. Miao, A.V. Ling, P.V. Manthena, M.E. Gearing, M.J. Graham, R.M. Crooke, K.J. Croce, R.M. Esquejo, C.B. Clish, Morbid Obesity Study G, and et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis Nat Commun 6 2015 6498
30. J.M. Ridlon, D.-J. Kang, and P.B. Hylemon Bile salt biotransformations by human intestinal bacteria J Lipid Res 47 2006 241 259
31. M. Begley, C.G.M. Gahan, and C. Hill The interaction between bacteria and bile FEMS Microbiol Rev 29 2005 625 651
32. K.K. Ryan, V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H.E. Wilson-Perez, D.A. Sandoval, R. Kohli, F. Backhed, and et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy Nature 509 2014 183 188
33. N.C. Penney, J.M. Kinross, R.C. Newton, and S. Purkayastha The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review Int J Obes (Lond) 2015
34. C. Thomas, R. Pellicciari, M. Pruzanski, J. Auwerx, and K. Schoonjans Targeting bile-acid signalling for metabolic diseases Nat Rev Drug Discov 7 2008 678 693
35. H. Bernstein, C. Bernstein, C.M. Payne, K. Dvorakova, and H. Garewal Bile acids as carcinogens in human gastrointestinal cancers Mutat Res 589 2005 47 65
36. S. Yoshimoto, T.M. Loo, K. Atarashi, H. Kanda, S. Sato, S. Oyadomari, Y. Iwakura, K. Oshima, H. Morita, M. Hattori, and et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome Nature 499 2013 97 101
37. L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. El Deiry, and et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis Mol Biol Cell 12 2001 2629 2645
38. J.L. Staudinger, B. Goodwin, S.A. Jones, D. Hawkins-Brown, K.I. MacKenzie, A. LaTour, Y. Liu, C.D. Klaassen, K.K. Brown, J. Reinhard, and et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity Proc Natl Acad Sci U S A 98 2001 3369 3374
39. S.I. Sayin, A. Wahlstrom, J. Felin, S. Jantti, H.-U. Marschall, K. Bamberg, B. Angelin, T. Hyotylainen, M. Oresic, and F. Backhed Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab 17 2013 225 235
40. R.D. DeMoss, and K. Moser Tryptophanase in diverse bacterial species J Bacteriol 98 1969 167 171
41. M.T. Jensen, R.P. Cox, and B.B. Jensen 3-Methylindole (skatole) and indole production by mixed populations of pig fecal bacteria Appl Environ Microbiol 61 1995 3180 3184
42. B. Gondouin, C. Cerini, L. Dou, M. Sallee, A. Duval-Sabatier, A. Pletinck, R. Calaf, R. Lacroix, N. Jourde-Chiche, S. Poitevin, and et al. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway Kidney Int 84 2013 733 744
43. P. Ramadoss, C. Marcus, and G.H. Perdew Role of the aryl hydrocarbon receptor in drug metabolism Expert Opin Drug Metab Toxicol 1 2005 9 21
44. T.V. Beischlag, J. Luis Morales, B.D. Hollingshead, and G.H. Perdew The aryl hydrocarbon receptor complex and the control of gene expression Crit Rev Eukaryot Gene Exp 18 2008 207 250
45. F. Matsumura The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects Biochem Pharmacol 77 2009 608 626
46. M. Warner, P. Mocarelli, P. Brambilla, A. Wesselink, S. Samuels, S. Signorini, and B. Eskenazi Diabetes, metabolic syndrome, and obesity in relation to serum dioxin concentrations: the Seveso women's health study Environ Health Perspect 121 2013 906 911
47. M. Yisireyili, H. Shimizu, S. Saito, A. Enomoto, F. Nishijima, and T. Niwa Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats Life Sci 92 2013 1180 1185
48. A.L. Neves, J. Coelho, L. Couto, A. Leite-Moreira, and R. Roncon-Albuquerque Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk J Mol Endocrinol 51 2013 R51 R64
49. J. Cheng, Y.M. Shah, and F.J. Gonzalez Pregnane X receptor as a target for treatment of inflammatory bowel disorders Trends Pharmacol Sci 33 2012 323 330
50. M. Venkatesh, S. Mukherjee, H. Wang, H. Li, K. Sun, A.P. Benechet, Z. Qiu, L. Maher, M.R. Redinbo, R.S. Phillips, and et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4 Immunity 41 2014 296 310
51. P.D. Cani, A.M. Neyrinck, F. Fava, C. Knauf, R.G. Burcelin, K.M. Tuohy, G.R. Gibson, and N.M. Delzenne Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia Diabetologia 50 2007 2374 2383
52. N.M. Delzenne, A.M. Neyrinck, F. Backhed, and P.D. Cani Targeting gut microbiota in obesity: effects of prebiotics and probiotics Nat Rev Endocrinol 7 2011 639 646
53. N.N. Kok, H.S. Taper, and N.M. Delzenne Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats J Appl Toxicol 18 1998 47 53
54. P.D. Cani, S. Hoste, Y. Guiot, and N.M. Delzenne Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats Br J Nutr 98 2007 32 37
55. H.S. Ejtahed, J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, and V. Mofid Probiotic yogurt improves antioxidant status in type 2 diabetic patients Nutrition 28 2012 539 543
56. A. Everard, C. Belzer, L. Geurts, J.P. Ouwerkerk, C. Druart, L.B. Bindels, Y. Guiot, M. Derrien, G.G. Muccioli, N.M. Delzenne, and et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc Natl Acad Sci U S A 110 2013 9066 9071
57. M.C. Dao, A. Everard, J. Aron-Wisnewsky, N. Sokolovska, E. Prifti, E.O. Verger, B.D. Kayser, F. Levenez, J. Chilloux, L. Hoyles, and et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology Gut 2015 in press
58. C. Moroti, L.F. Souza Magri, M. de Rezende Costa, D.C.U. Cavallini, and K. Sivieri Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus Lipids Health Dis 11 2012 29
59. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
60. V.K. Ridaura, J.J. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, N.W. Griffin, V. Lombard, B. Henrissat, J.R. Bain, and et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
61. A. Vrieze, E. Van Nood, F. Holleman, J. Salojarvi, R.S. Kootte, J.F.W.M. Bartelsman, G.M. Dallinga-Thie, M.T. Ackermans, M.J. Serlie, R. Oozeer, and et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome Gastroenterology 143 2012 913 916 e917
62. E.F. Murphy, P.D. Cotter, A. Hogan, O. O'Sullivan, A. Joyce, F. Fouhy, S.F. Clarke, T.M. Marques, P.W. O'Toole, C. Stanton, and et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity Gut 62 2013 220 226
63. E. Gough, H. Shaikh, and A.R. Manges Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection Clin Infect Dis 53 2011 994 1002
64. E. Meader, M.J. Mayer, D. Steverding, S.R. Carding, and A. Narbad Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system Anaerobe 22 2013 25 30
65. Z. Drulis-Kawa, G. Majkowska-Skrobek, B. Maciejewska, A.S. Delattre, and R. Lavigne Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications Curr Protein Pept Sci 13 2012 699 722